SCHEMBL4337649

SCHEMBL4337649

CCOC(=O)CCCCCc1nc(-c2ccccc2)c(-c2ccc(Cl)cc2)o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2C19 P33261 2/20 0.65
MEN1 O00255 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2C9 P11712 1/20 0.65
KMT2A Q03164 1/20 0.65
RXRA P19793 13/20 0.64
RXRB P28702 13/20 0.64
RXRG P48443 10/20 0.64
NR4A2 P43354 7/20 0.61
HPGD P15428 3/20 0.57
ALDH1A1 P00352 2/20 0.57
NR4A1 P22736 2/20 0.54
NR4A3 Q92570 2/20 0.54
PTGS1 P23219 2/20 0.53
EPHX2 P34913 2/20 0.53
PTGS2 P35354 2/20 0.53
ABCC4 O15439 1/20 0.53
C5 P01031 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4320438 0.94 RXRA (0.70) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4337631 0.90 RXRA (0.61) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4330498 0.88 RXRA (0.59) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4335073 0.87 RXRA (0.59) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4327894 0.86 RXRA (0.83) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4333227 0.85 FAAH (0.61) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4323846 0.84 RXRA (0.53) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4322068 0.84 RXRA (0.54) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL4341788 0.84 RXRA (0.54) KDM4ECYP3A4CYP2C19MEN1CYP1A2
SCHEMBL7502488 0.83 RXRA (0.58) KDM4ECYP3A4CYP2C19MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521563-B2 Hydroxamic acid derivative and medicine containing the same as active ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2009-04-21 US disclosed
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2007-09-06 US disclosed
EP-1787986-A1 HYDROXAMIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIZUOKA COFFEIN CO., LTD. (JP) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient IL6, IL1A, TNF KDM4E 1921/4885CYP3A4 2548/4885CYP2C19 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.